College Hill Life Sciences wins corporate and financial brief with Qiagen

College Hill's Life Sciences team has won a brief to provide corporate and financial PR for sample and assay technologies company Qiagen.

College Hill Life Sciences managing partner: Sue Charles
College Hill Life Sciences managing partner: Sue Charles

The NASDAQ 100-listed company has appointed following its work with molecular diagnostics company DxS, which was acquired by Qiagen in 2009.

The UK and US account team will focus on targeting the US markets and raising QIAGEN's corporate leadership profile on an international basis.

In addition to the corporate and financial brief, College Hill Life Sciences retains the DxS account, which specialises in personalised medicine and companion diagnostics.

College Hill Life Sciences managing partner Sue Charles said: ‘We will be working with QIAGEN on its global brief to communicate how it has built itself into a successful company and the potential it has to make a difference to healthcare. 


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in